Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Dapito, Dianne H., Mencin, Ali, Gwak, Geum-Youn, Pradere, Jean-Philippe, Jang, Myoung-Kuk, Mederacke, Ingmar, Caviglia, Jorge M., Khiabanian, Hossein +8 more·2012·Cancer Cell

DOI 10.1016/j.ccr.2012.02.007

Cited by (1,000)

Items 401–500 of 1,000

Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis
Simona Valeria Clichici, Luminița David, Bianca Elena Moldovan, Ioana Bâldea, Diana Elena Olteanu, Mara Filip, Andras Laszlo Nagy, Vlad Luca, Carmen Bianca Crivii, Petru Adrian Mircea et al. · 2020 · Materials Science and Engineering C
Design principles for bacteria-responsive antimicrobial nanomaterials
Jing Yang Quek, Evelyn Osehontue Uroro, Nirmal Goswami, Krasimir A. Vasilev · 2021 · Materials Today Chemistry
Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
Shuyu Liu, Xilan Yang · 2023 · Frontiers in Cellular and Infection Microbiology
Foodomics as part of the host-microbiota-exposome interplay
Lorenza Putignani, Bruno Dallapiccola · 2016 · Journal of Proteomics
Promotion and induction of liver cancer by gut microbiome-mediated modulation of bile acids
Baolei Jia, Che Ok Jeon · 2019 · PLoS Pathogens
Interplay Between Macrophages and Angiogenesis: A Double-Edged Sword in Liver Disease
Marta Ramírez-Pedraza, Mercedes Fernández · 2019 · Frontiers in Immunology
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Sally Naji Temraz, Farah J. Nassar, Firas Kreidieh, Deborah Mukherji, Ali I. Shamseddine, Rihab Nasr · 2021 · International Journal of Molecular Sciences
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Norihisa Nishimura, Kosuke Kaji, Koh Kitagawa, Yasuhiko Sawada, Masanori Furukawa, Takahiro Ozutsumi, Yukihisa Fujinaga, Yuki Tsuji, Hiroaki Takaya, Hideto Kawaratani et al. · 2021 · International Journal of Molecular Sciences
Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine
Takanori Ochi, Yongjia Feng, Sho Kitamoto, Hiroko Nagao‐Kitamoto, Peter Kuffa, Koji Atarashi, Kenya Honda, Daniel H. Teitelbaum, Nobuhiko Kamada · 2016 · Scientific Reports
Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways
Reham M. Essam, Lamiaa A. Ahmed, Rania M. Abdelsalam, Aiman Saad El-Khatib · 2019 · Life Sciences
DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model
Achiwa, Koichi, Ishigami, Masatoshi, Ishizu, Yoji, Kuzuya, Teiji, Honda, Takashi, Hayashi, Kazuhiko, Hirooka, Yoshiki, Katano, Yoshiaki, Goto, Hidemi · 2016 · Biochemical and Biophysical Research Communications
Epiregulin as a therapeutic target in non-small-cell lung cancer
Noriaki Sunaga, Kyoichi Kaira · 2015 · Lung Cancer Targets and Therapy
Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway
Xiaying Zhao, Jing Fu, An Xu, Le‐Xing Yu, Junjie Zhu, Rongyang Dai, Bo Su, Tao Luo, Na Li, Wei-Han Qin et al. · 2015 · Cell Death and Disease
Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
Antonio Riva, Elizabeth H. Gray, Sarah Azarian, Ane Zamalloa, Mark J.W. McPhail, Royce P Vincent, Roger L. Williams, Shilpa Chokshi, Vishal Patel, Lindsey Ann Edwards · 2020 · JHEP Reports
Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation
Mengyun Ke, Tao Xu, Yi Fang, Yuanpeng Ye, Zhi-jin Li, Fenggang Ren, Shaoying Lu, Xu‐Feng Zhang, Rongqian Wu, Yi Lv et al. · 2021 · Cancer Letters
Recent updates on the role of the gut-liver axis in the pathogenesis of NAFLD/NASH, HCC, and beyond
Naoko Ohtani, Tomonori Kamiya, Norifumi Kawada · 2023 · Hepatology Communications
Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells
Chih‐Cheng Hsiao, Po‐Han Chen, Cheng‐I Cheng, Ming‐Shian Tsai, Chih-Yang Chang, Shang-Chieh Lu, Ming-Chu Hsieh, Yu‐Chun Lin, Po‐Huang Lee, Ying-Hsien Kao · 2015 · Cancer Letters
The role of gut microbiota in liver disease development and treatment
Lijun Wang, Yu‐Jui Yvonne Wan · 2019 · Liver Research
Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats
Huiyong Jiang, Yan Ren, Kaicen Wang, Qiangqiang Wang, Xiaoxiao Chen, Lifeng Chen, Lanjuan Li, Longxian Lv · 2020 · Biomedicine & Pharmacotherapy
Cellular senescence in the tumor microenvironment and context‐specific cancer treatment strategies
Tadahito Yasuda, Hideo Baba, Takatsugu Ishimoto · 2021 · FEBS Journal
Potential links between the microbiota and T cell immunity determine the tumor cell fate
Amir Hossein Mohseni, Sedigheh Taghinezhad‐S, Vincenzo Casolaro, Zhongwei Lv, Dan Li · 2023 · Cell Death and Disease
Roles of the gut microbiota in hepatocellular carcinoma: from the gut dysbiosis to the intratumoral microbiota
Yiqin Wang, Yongqiang Li, Yong Lin, Chuang-Yu Cao, Dongcheng Chen, Xian Huang, Canhua Li, Haoming Xu, Huasheng Lai, Huiting Chen et al. · 2025 · Cell Death Discovery
Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes
Geoffrey J. Markowitz, Pengyuan Yang, Jing Fu, Gregory Alexander Michelotti, Rui Chen, Jianhua Sui, Bin Yang, Wenhao Qin, Zheng Zhang, Fu‐Sheng Wang et al. · 2016 · Cancer Research
AIM2 deficiency reduces the development of hepatocellular carcinoma in mice
Claudia Martínez‐Cardona, Beatriz Lozano‐Ruiz, Victoria Bachiller, Gloria Peiró, Francisco Algaba‐Chueca, Isabel Gómez‐Hurtado, José M. Such, Pedro Zapater, Rubén Francés, José Manuel González-Navajas · 2018 · International Journal of Cancer
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Gomes Rodrigues, Van der Merwe, Aleksander Ahm Krag, Reiner Wiest · 2024 · Seminars in Immunology
Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Alejandro Rubio-Zarapuz, Alexandra Martín-Rodríguez, José Francisco Tornero-Aguilera · 2024 · Biomedicines
Gut–Liver–Pancreas Axis Crosstalk in Health and Disease: From the Role of Microbial Metabolites to Innovative Microbiota Manipulating Strategies
Giada Marroncini, Laura Naldi, Serena Martinelli, Amedeo Amedei · 2024 · Biomedicines
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, Xiaoping Chen, Bixiang Zhang, Zhao Huang · 2024 · Clinical and Molecular Hepatology
Probiotics and Liver Disease
Vishal Sharma, Shashank Garg, Sourabh Aġġarwal · 2013 · The Permanente Journal
Road to stemness in hepatocellular carcinoma
Teresita del N.J. Flores-Téllez, Saúl Villa‐Treviño, Carolina Piña‐Vázquez · 2017 · World Journal of Gastroenterology
NLRP12 suppresses hepatocellular carcinoma via downregulation of cJun N-terminal kinase activation in the hepatocyte
S. M. Nashir Udden, Youn-Tae Kwak, Victoria Godfrey, Md Abdul Wadud Khan, Shahanshah Khan, Nicolas Loof, Lan Peng, Hao Zhu, Hasan Zaki · 2019 · eLife
Oral microbial community analysis of the patients in the progression of liver cancer
Daxu Li, Weijun Xi, Zhe Zhang, Le Ren, Chunni Deng, Jianghao Chen, Cong Sun, Nan Zhang, Jiru Xu · 2020 · Microbial Pathogenesis
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study
Fedirko, Veronika, Tran, Hao Quang, Gewirtz, Andrew T., Stepien, Magdalena, Trichopoulou, Antonia, Aleksandrova, Krasimira, Olsen, Anja, Tjønneland, Anne, Overvad, Kim, Carbonnel, Franck et al. · 2017 · BMC Medicine
The Gut Microbiome and Ferroptosis in MAFLD
Jie Ji, Liwei Wu, Jue Wei, Jianye Wu, Chuanyong Guo · 2022 · Journal of Clinical and Translational Hepatology
Colonization Potential to Reconstitute a Microbe Community in Pseudo Germ-Free Mice After Fecal Microbe Transplant From Equol Producer
Wenou Liang, Lichao Zhao, Jingfeng Zhang, Xiang Fang, Qingping Zhong, Zhenlin Liao, Jie Wang, Yingyu Guo, Huijun Liang, Li Wang · 2020 · Frontiers in Microbiology
A role for intestinal alkaline phosphatase in preventing liver fibrosis
Yang Liu, Paul M. Cavallaro, Byeong–Moo Kim, Tao Liu, Hongyan Wang, Florian Kühn, Fatemeh Adiliaghdam, Enyu Liu, Robin V. Vasan, Ehsan Samarbafzadeh et al. · 2020 · Theranostics
Fibroblasts in liver cancer: functions and therapeutic translation
Affo, Silvia, Filliol, Aveline, Gores, Gregory J, Schwabe, Robert F · 2023 · The Lancet Gastroenterology & Hepatology
The Post-amyloid Era in Alzheimer's Disease: Trust Your Gut Feeling
Carolina Pereira Osorio, Tulasi Kanukuntla, Eddie Lee Diaz, Nyla Jafri, Michael Cummings, Adonis Sfera · 2019 · Frontiers in Aging Neuroscience
Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
Weizheng Zhang, Xiaosong Xu, Liping Cai, Xiangsheng Cai · 2023 · Scientific Reports
TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production
Ga Bin Park, Daejin Kim · 2016 · Molecular and Cellular Biochemistry
Attenuation of Innate Immunity by Andrographolide Derivatives Through NF-κB Signaling Pathway
Xin Nie, Shaoru Chen, Kun Wang, Yuran Peng, Yitao Wang, Decai Wang, Ying Wang, Guo‐Chun Zhou · 2017 · Scientific Reports
Nonalcoholic fatty liver disease promotes hepatocellular carcinoma through direct and indirect effects on hepatocytes
Chi Ma, Qianfei Zhang, Tim F. Greten · 2017 · FEBS Journal
Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment
Keita Kouzu, Hironori Tsujimoto, Yoji Kishi, Hideki Ueno, Nariyoshi Shinomiya · 2022 · Biomedicines
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma
Yang Song, Harry Cheuk-Hay Lau, Xiang Zhang, Jun Qing Yu · 2023 · Cancer Biology and Medicine
Liver Ischemic Preconditioning (IPC) Improves Intestinal Microbiota Following Liver Transplantation in Rats through 16s rDNA-Based Analysis of Microbial Structure Shift
Zhigang Ren, Guangying Cui, Haifeng Lu, Xinhua Chen, Jianwen Jiang, Hui Liu, Yong He, Songming Ding, Zhenhua Hu, Weilin Wang et al. · 2013 · PLoS ONE
Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma
Antonio Sircana, Elena Paschetta, Francesca Saba, Federica Molinaro, Giovanni Musso · 2019 · International Journal of Molecular Sciences
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Ibrahim Javed, Xuejing Cui, Xiaoyu Wang, Monika Mortimer, Nikolaos K. Andrikopoulos, Yuhuan Li, Thomas Paul Davis, Yuliang Zhao, Pu Chun Ke, Chunying Chen · 2020 · ACS Nano
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Jin Zhou, Madhulika Tripathi, Rohit A. Sinha, Brijesh Kumar Singh, Paul M. Yen · 2021 · Hepatoma Research
Manipulating Liver Bile Acid Signaling by Nanodelivery of Bile Acid Receptor Modulators for Liver Cancer Immunotherapy
Guofeng Ji, Xinghui Si, Si Dong, Yajun Xu, Mingqiang Li, Bo Yang, Zhaohui Tang, Xuedong Fang, Leaf Huang, Wantong Song et al. · 2021 · Nano Letters
Ginsenoside Rk3 Suppresses Hepatocellular Carcinoma Development through Targeting the Gut-Liver Axis
Linlin Qu, Xiaoxuan Ma, Daidi Fan · 2021 · Journal of Agricultural and Food Chemistry
Gut dysbiosis conveys psychological stress to activate LRP5/β-catenin pathway promoting cancer stemness
Cui Bai, Huandong Luo, Bin He, Xinyu Liu, Dekang Lv, Xiaoyu Zhang, Keyu Su, Sijia Zheng, Jinxin Lü, Cenxin Wang et al. · 2025 · Signal Transduction and Targeted Therapy
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
Blanche C. Ip, Xiangdong Wang · 2013 · Nutrients
TLR4-Dependent Secretion by Hepatic Stellate Cells of the Neutrophil-Chemoattractant CXCL1 Mediates Liver Response to Gut Microbiota
Amélie Bigorgne, Beena John, Mo R. Ebrahimkhani, Masami Shimizu‐Albergine, Jean S. Campbell, Ian Nicholas Crispe · 2016 · PLoS ONE
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
Marion Dajon, Kristina Iribarren, Florent Petitprez, Solenne Marmier, Audrey Mansuet‐Lupo, Mélanie Gillard, Hanane Ouakrim, Navas Victor, Vincenzo Di Bartolo, Pierre-Emmanuel Joubert et al. · 2018 · OncoImmunology
Effects of the 1975 Japanese diet on the gut microbiota in younger adults
Mamoru Kushida, Saeko Sugawara, Masaki Asano, Kazushi Yamamoto, Shinji Fukuda, Tsuyoshi Tsuduki · 2018 · The Journal of Nutritional Biochemistry
Microbiome dysbiosis and alcoholic liver disease
Fengyuan Li, Craig James McClain, Wenke Feng · 2019 · Liver Research
Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease—one of a kind or two different enemies?
Christine Pocha, Chencheng Xie · 2019 · Translational Gastroenterology and Hepatology
Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
Sana Raza, Sangam Rajak, Baby Anjum, Rohit A. Sinha · 2019 · Hepatoma Research
Association between the microbiota and women’s cancers – Cause or consequences?
Negin Alizadehmohajer, Samaneh Shojaeifar, Reza Nedaeinia, Mojgan Esparvarinha, Forogh Mohammadi, Gordon A. Ferns, Majid Ghayour‐Mobarhan, Mostafa Manian, Adele Balouchi · 2020 · Biomedicine & Pharmacotherapy
Diethylnitrosamine-induced liver tumorigenesis in mice
Isabel Schulien, Peter Hasselblatt · 2020 · Methods in cell biology
Antidepressant-like effects of Schisandrin on lipopolysaccharide-induced mice : Gut microbiota, short chain fatty acid and TLR4/NF-κB signaling pathway
Yingying Sun, Tingxu Yan, Guowei Gong, Yue Li, Jingying Zhang, Bo Wu, Kaishun Bi, Ying Jia · 2020 · International Immunopharmacology
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
Lilong Zhang, Chen Chen, Dongqi Chai, Chunlei Li, Yongjun Guan, Li Liu, Tianrui Kuang, Wenhong Deng, Weixing Wang · 2022 · Frontiers in Immunology
Effects of glyphosate exposure on gut–liver axis: Metabolomic and mechanistic analysis in grass carp (Ctenopharyngodon idellus)
Biao Yan, Yumiao Sun, Kaiyu Fu, Yindan Zhang, Lei Lei, Jun Men, Yongyong Guo, Shengmin Wu, Jian Zhong Han, Bingsheng Zhou · 2023 · The Science of The Total Environment
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development
Chunmeng Jiang · 2014 · World Journal of Gastroenterology
Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis
Patrick Wainwright, Eleonora Scorletti, Christopher D. Byrne · 2017 · Current Diabetes Reports
Optimal immunosuppressor induces stable gut microbiota after liver transplantation
Jianwen Jiang, Zhigang Ren, Haifeng Lu, Hua Zhang, Ang Li, Guangying Cui, Junjun Jia, Haiyang Xie, Xinhua Chen, Yong He et al. · 2018 · World Journal of Gastroenterology
Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
Muhammad Shahid Riaz Rajoka, Hafiza Mahreen Mehwish, Yongai Xiong, Xun Song, Nazim Hussain, Qinchang Zhu, Zhendan He · 2020 · Trends in Food Science & Technology
Associations of the gut microbiome with hepatic adiposity in the Multiethnic Cohort Adiposity Phenotype Study
Meredith A.J. Hullar, Isaac Jenkins, Timothy W. Randolph, Keith R. Curtis, Kristine R. Monroe, Thomas M. Ernst, J. Shepherd, Daniel O. Stram, Iona C. Cheng, Bruce S. Kristal et al. · 2021 · Gut Microbes
The Relationship Between Microbial Community and Breast Cancer
Xuelian Song, Changran Wei, Xiangqi Li · 2022 · Frontiers in Cellular and Infection Microbiology
[Retracted] Multifunctional Therapeutic Approach of Nanomedicines against Inflammation in Cancer and Aging
Md. Mominur Rahman, Fahadul Islam, Sadia Afsana Mim, Md. Shajib Khan, Md. Rezaul Islam, Md. Anamul Haque, Saikat Mitra, Talha Bin Emran, Abdur Rauf · 2022 · Journal of Nanomaterials · Retracted
Current therapeutic modalities and chemopreventive role of natural products in liver cancer: Progress and promise
Amit Kumar Singh, Shiv Vardan Singh, Ramesh Kumar, Shashank Kumar, Sabyasachi Senapati, Abhay Kumar Pandey · 2023 · World Journal of Hepatology
HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2
Weibo Feng, Jie Chen, Wenjie Huang, Guodong Wang, Xilang Chen, Lili Duan, Yue Yin, Xiaoping Chen, Bixiang Zhang, Mengyu Sun et al. · 2023 · Theranostics
Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
Qi Zheng, Jing Yang, Min Li · 2015 · Journal of Hepatocellular Carcinoma
Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr mice by targeting the TGFβ-Smad3 pathway
Lytle, Kelli A., Depner, Christopher M., Wong, Carmen P., Jump, Donald B. · 2015 · Journal of Lipid Research
Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
Alejandro Torres-Hernandez, Wei Wang, Yuri E. Nikiforov, Karla Tejada, Luisana E. Torres, Aleksandr Kalabin, Yue Wu, Muhammad Israr Ul Haq, Mohammed Y. Khan, Zhen Zhao et al. · 2019 · Oncogene
Role of Gut Microbiota in Combating Oxidative Stress
Bomba Dam, Arijit Misra, Sohini Banerjee · 2019 · Springer eBooks
TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme—Future Perspectives
Jakub Litak, Cezary Grochowski, Joanna Litak, Ida Osuchowska, Krzysztof Gosik, Elżbieta Radzikowska, Piotr Kamieniak, Jacek Roliński · 2020 · International Journal of Molecular Sciences
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Kevin De Muynck, Bart Vanderborght, Hans Van Vlierberghe, Lindsey Devisscher · 2021 · Cells
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico · 2021 · Frontiers in Medicine
Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma
Fang Jia-Zhu, Chong Li, Xiao-Yan Liu, Hu Tao-Tao, Zusen Fan, Ze‐Guang Han · 2015 · PLoS ONE
The DEN and CCl 4 ‐Induced Mouse Model of Fibrosis and Inflammation‐Associated Hepatocellular Carcinoma
Takeki Uehara, Igor P. Pogribny, Ivan Rusyn · 2021 · Current Protocols
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sevag Hamamah, Oana Camelia Iatcu, Mihai Covașă · 2024 · Nutrients
Inflammation in MASLD progression and cancer
Yeonsoo Kim, Yunseo Park, H. Rho, Tiantian Yao, Bin Gao, Seonghwan Hwang · 2025 · JHEP Reports
Microbe–MUC1 Crosstalk in Cancer-Associated Infections
Mukulika Bose, Pinku Mukherjee · 2019 · Trends in Molecular Medicine
Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma
Shan Gao, Tianxiang Chen, Lijie Li, Xin Liu, Yang Liu, Junjun Zhao, Qiliang Lu, Zhi Rong Zeng, Qiuran Xu, Dongsheng Huang et al. · 2020 · Frontiers in Cell and Developmental Biology
The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
Paulraj Kanmani, Suganya Kanmani, Hojun Kim · 2020 · Biomedicines
Mouse Models of Liver Cancer
Jorge Matías Caviglia, Robert F. Schwabe · 2015 · Methods in molecular biology
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Nicolò Brandi, Matteo Renzulli · 2023 · International Journal of Molecular Sciences
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, Fan Yang, Yan Yu, Zhiyong Qian · 2024 · Theranostics
Therapeutic Opportunities in Damage-Associated Molecular Pattern-Driven Metabolic Diseases
Irma García‐Martinez, Mohamed E. Shaker, Wajahat Zafar Mehal · 2015 · Antioxidants and Redox Signaling
Oral Administration of Saccharomyces boulardii Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Reducing Intestinal Permeability and Modulating Gut Microbial Composition
Ming Li, Lin Zhu, Ao Xie, Jieli Yuan · 2014 · Inflammation
Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway
Yuqing Dong, Chuan-Wei Lu, Lu Zhang, Jia Yi Yang, Waqaar Hameed, Wei Chen · 2015 · Molecular Immunology
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis
Ki Tae Suk, Ingmar Mederacke, Geum‐Youn Gwak, Sung Won Cho, Adebowale Adeyemi, Richard A. Friedman, Robert F. Schwabe · 2016 · Gut
Microbiota and the liver
Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi · 2018 · Liver Transplantation
Grow With the Challenge – Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy
Jakob von Frieling, Christine Fink, Jacob Hamm, Kenneth Klischies, Michael Förster, Thomas C. G. Bosch, Thomas Roeder, Philip C Rosenstiel, Felix Sommer · 2018 · Frontiers in Microbiology
Is it true that gut microbiota is considered as panacea in cancer therapy?
Amir Salek Farrokhi, Narges Darabi, Bahman Yousefi, Rafee Habib Askandar, Mansoreh Shariati, Majid Eslami · 2019 · Journal of Cellular Physiology
The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
Nahum M�ndez-S�nchez, Alejandro Valencia-Rodríguez, Alfonso Vera-Barajas, Ludovico Abenavoli, Emidio Scarpellini, Guadalupe Ponciano Rodríguez · 2020 · Hepatoma Research
Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5‐fluorouracil in vivo by increasing curcumin bioavailability
Meng Jin, Li Kong, Ying Han, Sen Zhang · 2021 · Phytotherapy Research
Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma
Jesús Rivera‐Esteban, Sergio Muñoz, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gómez, M Serra Cusidó, Alba Jiménez-Masip, Sven Francque et al. · 2024 · Clinical Gastroenterology and Hepatology
Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders
Cynthia Rajani, Wei Ping Jia · 2018 · Clinical Science